Pnemotex®
Pneumococcal conjugate vaccine (13-valent, adsorbed).1
Indications
Prevention of pneumococcal infection caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7 °F, 9V, 14, 18 °C, 19A, 19 °F, and 23 °F.1.
Age of Use
For children from 2 months of age and adults1.
Vaccination Schedule
- Initiation at 2–6 months of age, schedules 3+1 or 2+1. Individual immunization: 3 doses at intervals of at least 4 weeks; a booster dose at 11–15 months.
- Mass immunization: 2 doses at intervals of at least 8 weeks; a booster dose at 12–15 months.
- Initiation at 7–11 months, schedule 2+1. 2 doses at intervals of at least 4 weeks; a booster dose in the second year of life.
- Initiation at 12–23 months, schedule 1+1. 2 doses at intervals of at least 8 weeks.
- Initiation at 2 years of age and older, schedule 1. A single dose.1,2
Manufacturing and Registration
- Marketing authorization holder: NANOLEK LLC.
- Registered in the Russian Federation since 2021.
- Manufactured at the NANOLEK Biomedical Complex since 2021.3
Official Documents
-
1.
Summary of Product Characteristics for «Pnemotex».
Accessed: 17.07.2025.
- 2.
-
3.
State Register of Medicinal Products
Accessed: 17.07.2025.